Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877552 · ClinicalTrials.gov registry record
Prospective Studies of the Pathogenesis of Schizophrenia
A clinical trial of Schizophrenia, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 598
- Enrollment target
- 1
- Study location
NCT00877552: Completed study of Schizophrenia, sponsored by University of North Carolina, Chapel Hill.
NCT00877552 is a study of Schizophrenia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 598 participants, above the 217-participant average among 315 other Schizophrenia trials with a reported enrollment target (176% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00877552, a study of Schizophrenia, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 598 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to use structural and functional magnetic resonance imaging (MRI) to study children at high risk for schizophrenia. It is hypothesized that children at high risk for schizophrenia will have abnormalities of brain development, especially of the cerebral cortex. The study will also describe normal brain development in children from birth to age 6 years
Conditions Studied
Study Locations (1)
North Carolina
- UNC Department of Psychiatry - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2002-08 |
| Est. Completion | 2019-12 |
What the finished NCT00877552 record still lists
NCT00877552 is an observational study that tracks outcomes without assigning an intervention. The registered 598 participants enrollment target is mid-sized for trials with a published cap, above the 217-participant average among 315 other Schizophrenia trials with a reported enrollment target (176% higher).
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 0 interventions.
NCT00877552 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00877552 about?
NCT00877552 is a clinical study titled "Prospective Studies of the Pathogenesis of Schizophrenia". The purpose of this study is to use structural and functional magnetic resonance imaging (MRI) to study children at high risk for schizophrenia. It is hypothesized that children at high risk for schizophrenia will have abnormalities of brain development, especially of the cerebral cortex. The study ...
What is the current status of trial NCT00877552?
This trial is currently completed. The enrollment target is 598 participants. The study started on 2002-08. Estimated completion is 2019-12.
What conditions does trial NCT00877552 study?
This clinical trial studies the following conditions: Schizophrenia.
Who is sponsoring clinical trial NCT00877552?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00877552 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00877552's enrollment target sits among peer trials
598 31st of 315 higher than 285 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Tolerability of MDMA in Schizophrenia
RECRUITING · Phase 1
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia